#India #Clinical Trials #Ahmedabad #Veeda Lifesciences #Drug Development Services

Veeda Group Rebrands as Veeda Lifesciences

In a significant move marking its evolution, Veeda Group has transitioned to a new identity, Veeda Lifesciences. Unveiled recently, this change reflects not just a new logo but symbolizes a broader shift in the company's strategy and offerings in the pharmaceutical sector.

Transitioning Focus
The rebranding denotes a strategic pivot from being primarily a Contract Research Organization (CRO) with a focus on generics to a more comprehensive service provider in drug development. Veeda Lifesciences will now operate across four strategic business units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and Preclinical Non-Clinical Testing Services. This change positions the company as an integrated research services provider, equipped to handle various phases of the drug development process.

Combining Strengths
The new brand amalgamates the capabilities of Veeda Clinical Research, Health Data Specialists, and Bioneeds India. These collaborative synergies allow the company to offer services across the entire drug development value chain, accommodating everything from discovery to late-stage development. The rebranding reflects a shift from generics to innovative solutions, local initiatives to global products, and small molecules to biologics, emphasizing Veeda Lifesciences' commitment to advancing the pharmaceutical landscape.

Incorporating Cutting-Edge Technology
Veeda Lifesciences is also shifting towards a CRO-CDMO model, which emphasizes the use of artificial intelligence and real-world data analysis in its processes. This will not only enhance the efficiency of the drug development process but also enable tailored solutions for clients in the ever-evolving biotech and pharmaceutical sectors.

In a statement, Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Lifesciences, articulated the vision behind the new identity: “The name and logo represent the group’s forward-thinking approach and unwavering commitment to our core values and mission. They add value to our growth and vision for the future as we strive for innovation, excellence, and customer satisfaction.”

Global Presence and Future Prospects
Established in 2004, Veeda Lifesciences has grown from its roots in India to operate in five countries while conducting studies in 26 nations. The strategic acquisition of Bioneeds in 2021 has significantly bolstered its preclinical service offering. Presently, Veeda Lifesciences delivers a wide array of services in the biopharmaceutical sector, catering to notable sponsors, including leading global pharmaceutical companies.

The Clinical Trials segment encompasses the company's European operations and patient-based clinical studies in India. The Healthy Volunteer Services focus on clinical bioanalysis for small molecules, while Biopharma Services in Bengaluru address tasks such as analytical and functional characterization of biologics along with clinical bioanalytical services for large molecules. The traditional preclinical testing services are further enhanced by expertise in both chemistry and biology, providing a well-rounded proposition to clients.

Veeda Lifesciences continues to innovate and prepare for its future, investing in talent and technology to assist in developing groundbreaking therapies and generics. As the company gears up for potential public offerings, it remains steadfast in its commitment to meet the needs of the evolving health landscape.

Conclusion

In conclusion, the rebranding of Veeda Lifesciences illustrates a key milestone in its journey, reflecting broader trends in the pharmaceutical and biopharmaceutical industries. As it embarks on this new chapter, Veeda Lifesciences is poised to make significant contributions to the healthcare sector.